Reproducibility is one of the biggest challenges in laboratory science, and reagent quality is one of its most controllable variables. With peptides, small differences in purity, identity and composition between lots can be enough to change an experimental outcome. Here is why purity matters, and how to account for it.
Where impurities come from
Solid-phase peptide synthesis builds a chain one amino acid at a time. Each step is highly efficient, but small losses at every step add up, particularly for longer sequences. Common impurities include:
- Deletion sequences: chains missing one or more amino acids because a coupling step was incomplete.
- Truncated sequences: chains that stopped growing early.
- Incompletely deprotected peptides: chains still carrying protecting groups on side chains.
- Diastereomers: chains in which an amino acid has racemized during synthesis.
- Oxidized or deamidated forms: modifications that can occur during synthesis, purification or storage.
- Residual TFA: trifluoroacetic acid from cleavage and purification, present as a counter-ion.
How impurities affect results
Many peptide impurities are structurally very similar to the target sequence, which is exactly what makes them a problem:
- Unexpected activity: a closely related sequence may still bind the target, bind a different target, or act as an antagonist.
- Lower effective concentration: if part of the material is not the target peptide, dose–response data shifts.
- Assay interference: residual TFA has been reported to affect cell proliferation and other readouts in some cell-based assays.
- Lot-to-lot variability: if the impurity profile changes between batches, results can change even when your protocol does not.
Choosing a purity grade
Required purity depends on the application. As a general guide:
| Purity | Typical research uses |
|---|---|
| Crude / >70% | Initial screening, antibody generation, non-quantitative work |
| >85% | Semi-quantitative studies, some enzyme and binding assays |
| >95% | Quantitative in-vitro assays, receptor–ligand studies, cell-based work |
| ≥98% | Sensitive quantitative studies, structural work, analytical reference standards |
When in doubt, higher purity reduces the number of variables you need to rule out when interpreting data.
Account for net peptide content
HPLC purity describes the peptide-related material the detector sees, but a lyophilized powder also contains water and counter-ions. If you calculate concentration from the gross weight of the powder alone, your actual peptide concentration will be lower. Where net peptide content is reported, use it; where it is not, treat concentrations as approximate and be consistent across experiments.
Building reproducibility into your workflow
- Record lot numbers for every reagent in your lab notebook and methods sections.
- Keep the COA for each lot alongside your data.
- Use a single lot across a related series of experiments where possible, and order enough to finish the series.
- Bridge new lots with a side-by-side comparison against the previous lot before switching.
- Include controls, such as a scrambled-sequence peptide, to separate sequence-specific effects from non-specific ones.
- Store and handle material consistently, following the guidance in our article on storing and handling lyophilized peptides.
The RC Supply standard
Every RC Supply lot is tested by independent laboratories, with HPLC for purity and mass spectrometry for identity, and must reach ≥98% purity before it is released. Each vial’s lot number links to its own certificate of analysis. Learn how to read a peptide COA, or browse our research compounds.
For laboratory research use only. RC Supply products are not drugs, food or cosmetics and are not intended for human or animal consumption, diagnostic or therapeutic use. This article is for educational purposes and does not constitute medical advice.




Leave a Reply